What Causes Cystic Fibrosis Cftr Mutations Explained?

Cystic fibrosis is caused by mutations in a single gene called CFTR. That gene carries the instructions for a protein that moves chloride and water across cell membranes. When the gene is mutated, the protein does not work properly, and thick sticky mucus builds up in the lungs, pancreas, and other organs. It is an inherited condition, passed down when a child receives one mutated copy of the gene from each parent.

What Is the CFTR Gene and What Does It Do?

CFTR stands for cystic fibrosis transmembrane conductance regulator. The gene sits on chromosome 7 and provides the blueprint for a protein of the same name. That protein forms a channel in the surface of cells, mainly in the lungs, sweat glands, pancreas, and intestines.

Its main job is to move chloride ions out of cells. Water follows chloride. In healthy airways, this flow keeps the thin layer of fluid lining the lungs at the right consistency, so mucus stays slippery and cilia can sweep it clear. The CFTR protein also helps regulate other channels, including one that controls sodium and water absorption.

When the CFTR protein is missing or faulty, chloride cannot move normally. Water movement changes, and mucus becomes thick and sticky instead of thin and watery. In the lungs, that mucus traps bacteria and is hard to clear. In the pancreas, it blocks ducts that carry digestive enzymes. In sweat glands, it changes how salt is handled, which is why people with cystic fibrosis have unusually salty sweat.

What Causes Cystic Fibrosis CFTR Mutations Explained

Cystic fibrosis is caused by changes in the DNA sequence of the CFTR gene. These changes are called mutations or variants. A mutation alters the instructions for building the CFTR protein, and depending on where and how the sequence changes, the protein may be missing, misfolded, or unable to function.

People inherit cystic fibrosis in an autosomal recessive pattern. That means a child must receive one mutated copy of the CFTR gene from each parent to have the disease. A person with one mutated copy and one normal copy is a carrier. Carriers do not have cystic fibrosis, though they can pass the mutated gene to their children.

If both parents are carriers, each child has a 1 in 4 chance of inheriting two mutated copies and having cystic fibrosis. Each child also has a 1 in 2 chance of being a carrier and a 1 in 4 chance of inheriting two normal copies. These odds apply to each pregnancy independently.

Most people with cystic fibrosis inherit a mutation from each parent. A smaller number have one inherited mutation and one new mutation that arose spontaneously in the sperm or egg that formed them. In rare cases, a person can have a mutation that is not found in either parent’s blood cells.

How Do Different CFTR Mutations Affect the Protein?

More than 2,000 variants have been identified in the CFTR gene, but not all of them cause disease. Researchers group the mutations that do cause cystic fibrosis into classes based on what goes wrong with the protein. This classification matters because different mutations respond differently to treatment.

• Class I: The protein is never made. Mutations stop production early.
• Class II: The protein is made but misfolded and never reaches the cell surface. The most common mutation, F508del, falls in this class.
• Class III: The protein reaches the cell surface but the channel gate does not open properly.
• Class IV: The channel opens but chloride moves through too slowly.
• Class V: Too little normal protein is produced.
• Class VI: The protein is unstable and breaks down quickly at the surface.

The F508del mutation, which deletes a single amino acid called phenylalanine at position 508, is the most common cause of cystic fibrosis worldwide. It accounts for a large share of mutations in people of European descent. Other mutations are more common in specific populations.

Why Do CFTR Mutations Cause Thick Mucus?

The link between a faulty chloride channel and thick mucus comes down to water. Mucus is mostly water. When chloride cannot leave cells normally, water does not follow it into the airway surface fluid. The result is mucus that is dehydrated, sticky, and hard to move.

This thick mucus causes problems throughout the body. In the lungs, it clogs small airways and creates a breeding ground for bacteria, which leads to chronic infection and inflammation. Over time, this damages lung tissue. In the pancreas, blocked ducts prevent digestive enzymes from reaching the intestine, which interferes with absorbing fats and proteins. In the liver, thickened secretions can block bile ducts in some people.

The sweat gland effect is different but useful for diagnosis. In sweat glands, the CFTR protein normally reabsorbs chloride from sweat before it reaches the skin. When the protein is faulty, chloride stays in the sweat, and sodium follows. That is why a sweat chloride test can detect cystic fibrosis. A sweat chloride result of 60 mmol/L or higher on two separate tests is a standard diagnostic threshold for cystic fibrosis.

Is Cystic Fibrosis Always Inherited From Both Parents?

In almost all cases, yes. Cystic fibrosis requires two mutated copies of the CFTR gene, one from each parent. A person with only one mutated copy is a carrier and does not develop the disease.

There are rare exceptions. A small number of people have one inherited mutation plus a new mutation that occurred spontaneously. In very rare cases, a genetic change in a different part of the CFTR gene can affect how the gene is read, and some people have a mutation that is present in only some of their cells. These situations are uncommon and usually identified through genetic testing.

Carrier screening can tell parents whether they carry a CFTR mutation before or during pregnancy. Because carriers have no symptoms, most people do not know their status unless they are tested. The American College of Obstetricians and Gynecologists recommends that carrier screening be offered to all women considering pregnancy, regardless of ethnicity, though the specific panel and approach can vary.

Can CFTR Mutations Be Prevented or Reversed?

CFTR mutations cannot be prevented. They are present at conception and are part of a person’s genetic makeup from the start. There is no lifestyle change, diet, or environmental factor that causes or prevents these mutations.

They also cannot be reversed. Gene editing to correct CFTR mutations in the body is an area of active research, but no approved therapy currently repairs the underlying mutation in a person’s cells. What has changed is the ability to treat the consequences of specific mutations.

A class of medications called CFTR modulators can improve the function of the faulty protein for certain mutations. These drugs do not fix the gene. They help the protein work better or reach the cell surface. Their availability and effectiveness depend on the specific mutation a person carries, which is why genetic testing is important. Not all mutations have a modulator that targets them.

It is also worth being clear about what these medications can and cannot do. They have changed outcomes for many people with certain mutations, but they are not a cure, and the evidence for each drug applies to specific mutation types and age groups. Some people do not respond, and long-term effects are still being studied.

What Role Do Genetics Play in How Severe Cystic Fibrosis Is?

The type of CFTR mutation is one factor in how cystic fibrosis affects a person, but it is not the only one. People with the same mutations can have different symptoms and different rates of lung decline. That variability tells researchers that other genes and environmental factors matter too.

Genes beyond CFTR, often called modifier genes, can influence lung function and other outcomes. Researchers have identified some of these, but the picture is incomplete. Environmental factors such as exposure to smoke, air pollution, and infections also affect how the disease progresses. Nutrition and access to care play a role as well.

This is why genetic testing identifies the mutation type but cannot predict an individual’s exact course. Two people with identical CFTR genotypes may have meaningfully different experiences of the disease.

How Is Cystic Fibrosis Diagnosed Through CFTR Testing?

Diagnosis combines clinical signs with lab testing. Newborn screening is standard in all US states and typically measures a marker called immunoreactive trypsinogen, followed by DNA testing for common CFTR mutations. A positive screen is not a diagnosis on its own and requires confirmation.

Confirmatory testing includes the sweat chloride test, genetic testing to identify CFTR mutations, and sometimes measurement of nasal potential difference. A sweat chloride of 60 mmol/L or higher on two occasions confirms cystic fibrosis in most cases. Results between 30 and 59 mmol/L are considered intermediate and may require further evaluation.

Genetic testing identifies which mutations a person carries. That information guides treatment decisions, especially for CFTR modulator eligibility, and helps families understand recurrence risk in future pregnancies.